Irska - engleski - HPRA (Health Products Regulatory Authority)

novartis ireland limited - calcitonin, salmon - nasal spray solution - 200 international unit - calcitonin (salmon synthetic)

Irska - engleski - HPRA (Health Products Regulatory Authority)

essential pharma (m) limited - calcitonin - solution for injection/infusion - 100 international unit(s)/millilitre - calcitonin preparations; calcitonin (salmon synthetic)

Irska - engleski - HPRA (Health Products Regulatory Authority)

essential pharma (m) limited - calcitonin - solution for injection/infusion - 50 international unit(s)/millilitre - calcitonin preparations; calcitonin (salmon synthetic)

Kanada - engleski - Health Canada

ferring inc - calcitonin (salmon synthetic) - liquid - 100unit - calcitonin (salmon synthetic) 100unit - parathyroid and antiparathyroid agents

Kanada - engleski - Health Canada

ferring inc - calcitonin (salmon synthetic) - liquid - 100unit - calcitonin (salmon synthetic) 100unit - parathyroid and antiparathyroid agents

Kanada - engleski - Health Canada

novartis pharmaceuticals canada inc - calcitonin (salmon synthetic) - liquid - 200unit - calcitonin (salmon synthetic) 200unit - parathyroid and antiparathyroid agents

Irska - engleski - HPRA (Health Products Regulatory Authority)

novartis pharmaceuticals uk ltd - calcitonin, salmon - solution for inj/inf - 100 iu/ml

Malta - engleski - Medicines Authority

essential pharma ltd 7 egham business village, crabtree road, egham, surrey, tw20 8rb , united kingdom - calcitonin, salmon - solution for injection - calcitonin, salmon 100 iu/ml - calcium homeostasis

Irska - engleski - HPRA (Health Products Regulatory Authority)

novartis pharmaceuticals uk ltd - calcitonin, salmon - solution for inj/inf - 50 iu/ml

Izrael - engleski - Ministry of Health

tzamal bio-pharma ltd - calcitonin salmon 200 iu/dose - nasal spray - calcitonin (salmon synthetic) - fortical® nasal spray is indicated for:postmenopausal osteoporosis – fortical® calcitonin-salmon (rdna origin) nasal spray isindicated for the treatment of postmenopausal osteoporosis in women greater than 5 yearspostmenopause with low bone mass relative to healthy premenopausal women. use of fortical®calcitonin-salmon (rdna origin) nasal spray is recommended in conjunction with an adequatecalcium (at least 1000 mg elemental calcium per day) and vitamin d (400 international units perday) intake to retard the progressive loss of bone mass. the evidence of efficacy for calcitoninsalmonis based on increases in spinal bone mineral density (bmd) observed in clinical trials